Aker BioMarine ASA Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	214.2	199	196.3	277.2	262.1	288.59
Revenue	214.2	199	196.3	277.2	262.1	288.59
Revenue Growth (YoY)	9.40%	1.38%	-29.18%	5.76%	-9.18%	17.23%
Cost of Revenue	130.8	129.9	123.8	162.4	174	176.03
Gross Profit	83.4	69.1	72.5	114.8	88.1	112.56
Selling, General & Admin	65.5	61	66.4	86.5	84.3	86.85
Other Operating Expenses	-2.7	-2	0.1	-4.4	-2.7	-0.09
Operating Expenses	79.7	74.4	82.8	98.5	95	103.84
Operating Income	3.7	-5.3	-10.3	16.3	-6.9	8.72
Interest Expense	-11.5	-2.5	-19.7	-20.3	-13.7	-18.74
Interest & Investment Income	3.2	3.6	1.5	0.6	-	0.88
Earnings From Equity Investments	-	-	-3	-	-	-
Currency Exchange Gain (Loss)	-1	-1	-0.8	8.1	0.6	-0.28
Other Non Operating Income (Expenses)	-7.2	-7.8	-	-1.7	-1.7	11.83
EBT Excluding Unusual Items	-12.8	-13	-32.3	3	-21.7	2.41
Gain (Loss) on Sale of Assets	-	-	-	-	0.4	1.31
Asset Writedown	-1.2	-1.2	-	-	-5.8	-0.04
Other Unusual Items	-	-	-	9.2	19.7	-2.98
Pretax Income	-14	-14.2	-32.3	12.2	-7.4	0.69
Income Tax Expense	-2	0.1	-	2.2	0.6	6.15
Earnings From Continuing Operations	-12	-14.3	-32.3	10	-8	-5.46
Earnings From Discontinued Operations	-24.6	194.6	23.3	-	-	-
Net Income	-36.6	180.3	-9	10	-8	-5.46
Net Income to Common	-36.6	180.3	-9	10	-8	-5.46
Shares Outstanding (Basic)	-	88	88	88	88	78
Shares Outstanding (Diluted)	-	88	88	88	88	78
Shares Change (YoY)	-	0.02%	0.04%	0.05%	12.20%	13.05%
EPS (Basic)	-	2.06	-0.10	0.11	-0.09	-0.07
EPS (Diluted)	-	2.06	-0.10	0.11	-0.09	-0.07
Free Cash Flow	-10.3	-5.2	1.5	-25.4	-76.1	-72.7
Free Cash Flow Per Share	-	-0.06	0.02	-0.29	-0.87	-0.93
Gross Margin	38.93%	34.72%	36.93%	41.41%	33.61%	39.00%
Operating Margin	1.73%	-2.66%	-5.25%	5.88%	-2.63%	3.02%
Profit Margin	-17.09%	90.60%	-4.58%	3.61%	-3.05%	-1.89%
Free Cash Flow Margin	-4.81%	-2.61%	0.76%	-9.16%	-29.04%	-25.19%
EBITDA	42.7	39.1	9.5	61.1	38.5	49.75
EBITDA Margin	19.93%	19.65%	4.84%	22.04%	14.69%	17.24%
D&A For EBITDA	39	44.4	19.8	44.8	45.4	41.03
EBIT	3.7	-5.3	-10.3	16.3	-6.9	8.72
EBIT Margin	1.73%	-2.66%	-5.25%	5.88%	-2.63%	3.02%
Effective Tax Rate	-	-	-	18.03%	-	894.04%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.